Krzysztof pitches Compass Pathways: both phase 3 trials of its pharmaceutical psilocybin are already positive, approval looks likely in early 2027, and the company holds 400-plus million in cash against about 40 million a quarter of burn, which by his math is ten quarters of runway. Stanford's Kevin Mak took a position, and Krzysztof walks through Mak's seven structural reasons the stock hasn't rerated. Luke explains gilt laddering as the cash sleeve of a portfolio, which turns into an argument about whether the US can grow its way out of $40 trillion of debt with the 30-year over 5%, and he names HSBC for fumbling his CyberArk payout nearly a year after Palo Alto closed the deal. Voting is open on the September community portfolio: Kraken Robotics, Rocket Lab and Shopify.
🍄 Should you buy $CMPS? The drug works, both phase 3 trials are positive, and the one grey area is whether insurers pay for a dose that needs six-plus hours of clinician supervision
🧠 Kevin Mak's seven reasons: a UK ADR no US index owns, thin institutions, career risk for any analyst who says "buy the magic mushroom stock", no valuation framework, M&A unpriced. A $2 billion company sitting at $15 resistance off a low of $2; Mak's number if you run it is about $45 a share
🗳️ September community portfolio: Kraken Robotics, $RKLB and $SHOP, voting is open at wallstreetwildlife.com
🚀 Luke's Rocket Lab average buy was $3-something; it got as high as $130 and is a $60-something stock now
🛍️ Paul thought $SHOP was overvalued until he opened his own storefront on it; Luke says Shopify got him across the line into early retirement
🧘 Beginner's mind: look at a stock you think you already know with fresh eyes
💷 Gilts in a minute: short-dated UK government bonds, refreshed every six months, as the cash you never leave idle
🇺🇸 The 30-year over 5% on $40 trillion of debt: growth has to beat the interest bill, which is why Krzysztof holds Bitcoin (and the crypto that is not a crypto that shall not be mentioned)
🏦 HSBC vs Trading 212 on the CyberArk acquisition: one converted in a day, one buried itself in bureaucracy and broken processes. Why you should have more than one broker once the numbers get big
💻 Luke is officially addicted to vibe coding
SOURCES:
Luke's Gilt webinar: https://youtu.be/HVVj0u1O6ms
Jared Isaacman (NASA): https://youtu.be/VTF6p0U98ek?si=DgSH8GOAA_MuM0jb
SEGMENTS:
00:00 Cold open
00:56 Jury Duty, the Amazon show: "a bit mid" or the kindest thing on TV?
06:03 Real jury duty, Bezos and Saylor on one panel, and AI judges
08:02 Luke is officially addicted to vibe coding
12:07 Livestream Monday, Patreon welcomes
14:21 A dark thought about capitalism: why are you investing, and what is enough?
19:13 What the community portfolio is, and why you should get involved
20:46 September pitches: Kraken Robotics $PNG, $RKLB and $SHOP, and beginner's mind
27:02 Fiscal.ai: fiscal.ai/wildlife, first week of Pro free, 15% off
28:03 Krzysztof already owns $RKLB, and the option that soured him
28:52 Isaacman at All-In: a moon base as the staging post to Mars
31:36 Paul's Shopify message: a merchant's beginner's mind
33:28 Should you buy $CMPS? The drug works, the cash runs ten quarters
40:31 Kevin Mak's seven structural reasons, the chart, and $45
44:25 Biotech corner: "I am a disco", Nektar, Relay, TransMedics
48:01 Cash doesn't have to sit idle: gilts and the gilt ladder
52:13 The 30-year over 5% on $40 trillion of debt: growth, Bitcoin, $ASST
57:59 Chainlink: the cryptocurrency that isn't a cryptocurrency
59:09 CyberArk deal: HSBC vs Trading 212, and why your broker matters
01:03:46 Wrap
Fiscal.AI is the Complete Stock Research Platform for fundamental investors. Get 15% off any premium plan with:
fiscal.ai/wildlife
Disclosure: Wall Street Wildlife hosts and guests are not financial advisors, and nothing they say on this show is formal advice or a recommendation
